Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Infertility in Males01:23

Infertility in Males

560
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
560
The Y Chromosome Determines Maleness02:19

The Y Chromosome Determines Maleness

8.1K
The Y chromosome is a sex chromosome found in several vertebrates and mammals, including humans. In addition to 22 pairs of autosomes, the human males have one X chromosome and one Y chromosome. In these organisms, the presence or absence of the Y chromosome determines the development of male traits.
Evolution
Around 300 million years ago, the two sex chromosomes diverged from two identical autosomal chromosomes. Over time, the Y chromosome has lost most of its genes, shrinking in size....
8.1K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.0K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.0K
Accessory Ducts of the Male Reproductive System01:25

Accessory Ducts of the Male Reproductive System

3.2K
The male reproductive system is a complex network of organs and tissues that work together to produce and transport sperm. The epididymis, vasa deferens, ejaculatory ducts, and urethra are the accessory ducts involved in sperm maturation and transportation. These ducts play a critical role in the production and transportation of sperm from the testes to the urethra, where it is then released during ejaculation.
The epididymis is a small, comma-shaped organ located at the back of each testicle....
3.2K
Accessory Glands of the Male Reproductive System01:16

Accessory Glands of the Male Reproductive System

3.4K
The accessory ducts involved in sperm maturation and transportation include the epididymides, vasa deferentia, ejaculatory ducts, and urethra. These ducts play a critical role in the maturation, storage, and transportation of sperm from the testes to the urethra, where it is then released during ejaculation.
The epididymis is a small, comma-shaped organ located at the back of each testicle. The epididymis can be divided into three main parts: the head, body, and tail. The head of the epididymis...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prospective trial of intraoperative tissue oxygenation measurement and its association with anastomotic leak rate after Ivor Lewis esophagectomy.

Journal of thoracic disease·2020
Same author

Asynchronous Bilateral Obturator Hernias: A Suggested Approach to Reduce Morbidity of Obturator Hernias.

Cureus·2019
Same author

Abdominal Apoplexy: A Case Study of Idiopathic Spontaneous Lesser Sac Hematoma.

Cureus·2019
Same author

Post Traumatic Pseudoaneurysm of Left Anterior Descending Artery Presenting as Acute Coronary Syndrome.

Cardiology research·2019
Same author

Role of Radiosurgery in the Treatment of Brain Metastasis.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2019
Same author

Bone Metastasis: Concise Overview.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2019

Related Experiment Video

Updated: Jan 29, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

14.6K

Prostate Cancer in Male Seniors Part 2: Treatment.

Hong W Chin1, Jyung Kim1, Gregory Rasp1

  • 1was chief of radiation oncology at the Dayton VAMC and a clinical professor at the Boomshoft School of Medicine of Wright State University, both in Dayton, Ohio. is chief of radiation oncology at John D. Dingell VAMC in Detroit, Michigan. and are assistant professors at Boonshoft Medical School of Wright State University. Dr. Hristov is also the chief of radiation oncology at Wright Patterson Air Force Base in Ohio.

Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS
|February 16, 2019
PubMed
Summary

Prostate cancer treatment choices depend on individual patient health. Key factors include life expectancy, functional status, and existing health conditions (comorbidities) for personalized care.

More Related Videos

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.7K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.2K

Related Experiment Videos

Last Updated: Jan 29, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

14.6K
Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.7K
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

11.2K

Area of Science:

  • Oncology
  • Geriatric Medicine
  • Clinical Decision-Making

Background:

  • Prostate cancer treatment requires careful consideration of patient-specific factors.
  • Individual health status significantly impacts treatment outcomes and patient well-being.

Purpose of the Study:

  • To emphasize the critical role of comprehensive patient assessment in guiding prostate cancer treatment decisions.
  • To highlight the importance of integrating life expectancy, functional performance, and comorbidities into treatment planning.

Main Methods:

  • Review of clinical guidelines and patient data relevant to prostate cancer management.
  • Analysis of factors influencing treatment efficacy and patient tolerance.

Main Results:

  • Patient health status, including life expectancy, is a primary determinant in selecting appropriate prostate cancer therapies.
  • Functional performance and the presence of comorbidities significantly affect treatment options and potential complications.

Conclusions:

  • Personalized treatment strategies for prostate cancer must be informed by a thorough evaluation of the patient's overall health.
  • Integrating assessments of life expectancy, functional status, and comorbidities ensures more effective and patient-centered prostate cancer care.